Cargando…

Blockade of Urotensin II Receptor Prevents Vascular Dysfunction

Urotensin II (UII) is a potent vasoactive peptide and mitogenic agent to induce proliferation of various cells including vascular smooth muscle cells (VSMCs). In this study, we examined the effects of a novel UII receptor (UT) antagonist, KR-36676, on vasoconstriction of aorta and proliferation of a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Young-Ae, Lee, Dong Gil, Yi, Kyu Yang, Lee, Byung Ho, Jung, Yi-Sook
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Applied Pharmacology 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5012878/ https://www.ncbi.nlm.nih.gov/pubmed/27582556 http://dx.doi.org/10.4062/biomolther.2015.142

Ejemplares similares

Inhibitory Effect of an Urotensin II Receptor Antagonist on Proinflammatory Activation Induced by Urotensin II in Human Vascular Endothelial Cells
por: Park, Sung Lyea, et al.
Publicado: (2013)

A Novel Urotensin II Receptor Antagonist, KR-36996 Inhibits Smooth Muscle Proliferation through ERK/ROS Pathway
por: Kim, Tae-Ho, et al.
Publicado: (2017)

Activation of the urotensin-II receptor by remdesivir induces cardiomyocyte dysfunction
por: Ogawa, Akiko, et al.
Publicado: (2023)

Urotensin II in cardiovascular regulation
por: Russell, Fraser D
Publicado: (2008)

Potential Clinical Implications of the Urotensin II Receptor Antagonists
por: Tsoukas, Philip, et al.
Publicado: (2011)

The Urotensin II System and Carotid Atherosclerosis: A Role in Vascular Calcification
por: Albanese, Isabella, et al.
Publicado: (2016)

Central and Peripheral Effects of Urotensin II and Urotensin II-Related Peptides on Cardiac Baroreflex Sensitivity in Trout
por: Lancien, Frédéric, et al.
Publicado: (2017)

Identification of new target proteins of a Urotensin-II receptor antagonist using transcriptome-based drug repositioning approach
por: Lim, Gyutae, et al.
Publicado: (2021)

Effects of Urotensin II Receptor Antagonist, GSK1440115, in Asthma
por: Portnoy, Alison, et al.
Publicado: (2013)

A new therapeutic approach to erectile dysfunction: urotensin-II receptor high affinity agonist ligands
por: di Villa Bianca, Roberta d’Emmanuele, et al.
Publicado: (2015)

Urotensin II-induced signaling involved in proliferation of vascular smooth muscle cells
por: Iglewski, Myriam, et al.
Publicado: (2010)

Urotensin II promotes aldosterone expression in rat aortic adventitial fibroblasts
por: Li, Jun, et al.
Publicado: (2018)

Divergent cardio-ventilatory and locomotor effects of centrally and peripherally administered urotensin II and urotensin II-related peptides in trout
por: Vanegas, Gilmer, et al.
Publicado: (2015)

The urotensin II receptor antagonist, urantide, protects against atherosclerosis in rats
por: ZHAO, JUAN, et al.
Publicado: (2013)

Evaluation of Endothelial Dysfunction in Bipolar Affective Disorders: Serum Endocan and Urotensin-II Levels
por: Oral, Elif, et al.
Publicado: (2019)

Urotensin II Induces Interleukin 8 Expression in Human Umbilical Vein Endothelial Cells
por: Lee, Chung-Yi, et al.
Publicado: (2014)

The Relationship between Urotensin II and its Receptor and the Clinicopathological Parameters of Breast Cancer
por: Balakan, Ozan, et al.
Publicado: (2014)

Urotensin II receptor as a potential biomarker for the prognosis of hepatocellular carcinoma patients
por: Wei, Hongtao, et al.
Publicado: (2017)

Urotensin II Promotes Atherosclerosis in Cholesterol-Fed Rabbits
por: Li, Yafeng, et al.
Publicado: (2014)

Urotensin-II: More Than a Mediator for Kidney
por: Balat, Ayşe, et al.
Publicado: (2012)

Role of Urotensin-II in Saphenous Vein Graft Disease
por: Tüysüz, Mehmet Erin, et al.
Publicado: (2020)

Urotensin II levels in patients with inflammatory bowel disease
por: Alicic, Damir, et al.
Publicado: (2021)

Urotensin II receptor determines prognosis of bladder cancer regulating cell motility/invasion
por: Franco, Renato, et al.
Publicado: (2014)

Urotensin-II Ligands: An Overview from Peptide to Nonpeptide Structures
por: Merlino, Francesco, et al.
Publicado: (2013)

A closer look at the role of urotensin II in the metabolic syndrome
por: Barrette, Pierre-Olivier, et al.
Publicado: (2012)

Urotensin II in Invertebrates: From Structure to Function in Aplysia californica
por: Romanova, Elena V., et al.
Publicado: (2012)

Irisin levels are associated with urotensin II levels in diabetic patients
por: He, Wan-Yu, et al.
Publicado: (2015)

The Role of Urotensin-II in Obesity and Metabolic Syndrome in Pediatric Population
por: Simunovic, Marko, et al.
Publicado: (2022)

Urotensin II level is elevated in inflammatory bowel disease patients
por: Zhang, Yan, et al.
Publicado: (2022)

Protective effect of urotensin II receptor antagonist urantide and exercise training on doxorubicin-induced cardiotoxicity
por: Sun, Jing, et al.
Publicado: (2023)

Plasma levels of urotensin II are increased in patients with three-vessel coronary artery disease and left ventricular dysfunction
por: Heringlake, M, et al.
Publicado: (2003)

Urotensin II levels in patients with chronic kidney disease and kidney transplants
por: Hursitoglu, Mehmet, et al.
Publicado: (2012)

Urotensin-II System in Genetic Control of Blood Pressure and Renal Function
por: Debiec, Radoslaw, et al.
Publicado: (2013)

Increased expression of urotensin II is associated with poor prognosis in hepatocellular carcinoma
por: Liu, Dian-Gang, et al.
Publicado: (2016)

The value of urotensin II in patients with left-sided rheumatic valvular regurgitation
por: Elmadbouh, Ibrahim, et al.
Publicado: (2017)

Expression of urotensin II is associated with placental autophagy in patients with severe preeclampsia
por: Pan, Ya-Jing, et al.
Publicado: (2018)

Serum Urotensin II Levels Are Elevated in Patients with Obstructive Sleep Apnea
por: Mihovilovic, Ante, et al.
Publicado: (2023)

The G Protein-Coupled Receptor UT of the Neuropeptide Urotensin II Displays Structural and Functional Chemokine Features
por: Castel, Hélène, et al.
Publicado: (2017)

The urotensin II receptor antagonist DS37001789 ameliorates mortality in pressure-overload mice with heart failure
por: Nishi, Mina, et al.
Publicado: (2020)

Conserved role of the urotensin II receptor 4 signalling pathway to control body straightness in a tetrapod
por: Alejevski, Faredin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_uf4kf53cioj6m2ljr939mdi66a